Mersana Therapeutics (MRSN) Presents XMT-1536 Interim Expansion Data from Phase 1 Study - Slideshow
Mersana Therapeutics(MRSN)2020-05-30 01:42
XMT-1536 Interim Expansion Data from Phase 1 Study May 27, 2020 Legal Disclaimer This presentation contains "forward-looking" statements within the meaning of federal securities laws. These forward-looking statements are not statements of historical facts and are based on management's beliefs and assumptions and on information currently available to management. Forward-looking statements include information concerning the Company's business strategy and the design, progression and timing of its clinical tri ...